| Presented by: | Archives of Pathology and Laboratory Medicine / Danielle E. Westfall, MD, Ling Zhang, MD, Sophie Song, MD, PhD and Stephen Lee, MD |
| Summary points: | A 65-year-old presents with nausea, vomiting, and diarrhoea 3 months after starting imatinib mesylate treatment for chronic myelogenous leukaemia. This case report describes the patient's history, laboratory and radiological tests, pathological findings, treatment, and outcome, and includes several images. The authors discuss the pathogenic effects of blast crises, criteria for erythroblast phase, as well as morphological and phenotypical features of the disease. |
Concurrent Megakaryocytic and Erythroid Chronic Myelogenous Leukemia Blast Crisis
